These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34384830)

  • 1. Differential expression of pyruvate dehydrogenase E1A and its inactive phosphorylated form among breast cancer subtypes.
    Zaher DM; Talaat IM; Hussein A; Hachim MY; Omar HA
    Life Sci; 2021 Nov; 284():119885. PubMed ID: 34384830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
    Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
    J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined evaluation of hexokinase 2 and phosphorylated pyruvate dehydrogenase-E1α in invasive front lesions of colorectal tumors predicts cancer metabolism and patient prognosis.
    Hamabe A; Yamamoto H; Konno M; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Nishida N; Kawamoto K; Koseki J; Doki Y; Mori M; Ishii H
    Cancer Sci; 2014 Sep; 105(9):1100-8. PubMed ID: 25060325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect.
    Fan J; Kang HB; Shan C; Elf S; Lin R; Xie J; Gu TL; Aguiar M; Lonning S; Chung TW; Arellano M; Khoury HJ; Shin DM; Khuri FR; Boggon TJ; Kang S; Chen J
    J Biol Chem; 2014 Sep; 289(38):26533-26541. PubMed ID: 25104357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
    Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
    Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis.
    Tong ZJ; Shi NY; Zhang ZJ; Yuan XD; Hong XM
    Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28667103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes.
    Gökmen-Polar Y; Mehta R; Tuzmen S; Mousses S; Thorat MA; Sanders KL; Turbin D; Leung S; Huntsman DG; Sledge GW; Badve S
    Breast Cancer Res Treat; 2010 Nov; 124(2):327-35. PubMed ID: 20099025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
    Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
    Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells.
    Ozden O; Park SH; Wagner BA; Song HY; Zhu Y; Vassilopoulos A; Jung B; Buettner GR; Gius D
    Free Radic Biol Med; 2014 Nov; 76():163-172. PubMed ID: 25152236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
    Lattanzio R; Iezzi M; Sala G; Tinari N; Falasca M; Alberti S; Buglioni S; Mottolese M; Perracchio L; Natali PG; Piantelli M
    BMC Cancer; 2019 Jul; 19(1):747. PubMed ID: 31362705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma.
    Sun J; Li J; Guo Z; Sun L; Juan C; Zhou Y; Gu H; Yu Y; Hu Q; Kan Q; Yu Z
    Oncol Res; 2019 Mar; 27(4):407-414. PubMed ID: 29444744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer.
    Oduwole OO; Li Y; Isomaa VV; Mäntyniemi A; Pulkka AE; Soini Y; Vihko PT
    Cancer Res; 2004 Oct; 64(20):7604-9. PubMed ID: 15492288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency.
    Karissa P; Simpson T; Dawson SP; Low TY; Tay SH; Nordin FDA; Zain SM; Lee PY; Pung YF
    Br J Biomed Sci; 2022; 79():10382. PubMed ID: 35996497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer.
    Casey MC; Prakash A; Holian E; McGuire A; Kalinina O; Shalaby A; Curran C; Webber M; Callagy G; Bourke E; Kerin MJ; Brown JA
    BMC Cancer; 2019 Jul; 19(1):712. PubMed ID: 31324173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between erb-B2 mRNA Expression in Blood and Tissue of Invasive Ductal Carcinoma Breast Cancer Patients and Clinicopathological Characteristics of the Tumors.
    Moazzezy N; Ebrahimi F; Sisakht MM; Yahyazadeh H; Bouzari S; Oloomi M
    Asian Pac J Cancer Prev; 2016; 17(1):249-54. PubMed ID: 26838218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.
    Fan J; Shan C; Kang HB; Elf S; Xie J; Tucker M; Gu TL; Aguiar M; Lonning S; Chen H; Mohammadi M; Britton LM; Garcia BA; Alečković M; Kang Y; Kaluz S; Devi N; Van Meir EG; Hitosugi T; Seo JH; Lonial S; Gaddh M; Arellano M; Khoury HJ; Khuri FR; Boggon TJ; Kang S; Chen J
    Mol Cell; 2014 Feb; 53(4):534-48. PubMed ID: 24486017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.